Immunomonitoring measures in relapsing-remitting multiple sclerosis

Journal of Neuroimmunology

Volumn 148, Issue 1-2, 2004, Pages 192-199

  Matsui, Makoto ^a   Araya, Shin Ich ^a   Wang, Hui Yun ^a   Matsushima, Kouji ^b   Saida, Takahiko ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cytokine; Flow cytometry; Multiple sclerosis; Surface antigen

Indexed keywords

BETA1 INTEGRIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; ARTICLE; CELL LEVEL; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE STATUS; LYMPHOCYTE; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; REMISSION; STAGING; TH1 CELL; TH2 CELL;

EID: 1242264279     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.11.020     Document Type: Article

References (35)

1. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6873-6878.
2. Becher B., Giacomini P.S., Pelletier D., McCrea E., Prat A., Antel J.P. Interferon-γ secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-β therapy. Ann. Neurol. 45:1999;247-250.
3. + T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol. Today. 19:1998;60-64.
4. Calopa M., Bas J., Mestre M., Arbizu T., Peres J., Buendia E. T cell subsets in multiple sclerosis: a serial study. Acta Neurol. Scand. 92:1995;361-368.
5. Chofflon M., Weiner H.L., Morimoto C., Hafler D.A. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+2H4+) T cells in multiple sclerosis. Ann. Neurol. 24:1988;185-911.
6. Clerici M., Saresella M., Trabattoni D., Speciale L., Fossati S., Ruzzante S., Cavaretta R., Filippi M., Caputo D., Ferrante P. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J. Neuroimmunol. 121:2001;88-101.
7. Comabella M., Balashov K., Issazadeh S., Smith D., Weiner H.L., Khoury S.J. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J. Clin. Invest. 102:1998;671-678.
8. + memory T lymphocytes in the peripheral blood of multiple sclerosis patients. Clin. Diag. Lab. Immunol. 2:1995;249-252.
9. Crucian B., Dunne P., Friedman H., Ragsdale R., Pross S., Widen R. Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis. Clin. Diag. Lab. Immunol. 3:1996;411-416.
10. Franciotta D., Zardini E., Bergamaschi R., Andreoni L., Cosi V. Interferon γ and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment. J. Neurol. Neurosurg. Psychiatry. 74:2003;123-126.
11. Hafler D.A., Weiner H.L. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144:1995;75-107.
12. Hafler D.A., Fox D.A., Manning M.E., Schlossman S.F., Reinherz E.L., Weiner H.L. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N. Engl. J. Med. 312:1985;1405-1411.
13. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., Gray P.W., Matsushima K., Yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11:1998;81-88.
14. Inogés S., Merino J., Bandrés E., De Castro P., Subirá M.L., Sánchez-Ibarrola A. Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients. Clin. Exp. Immunol. 115:1999;521-525.
15. Kastrukoff L.F., Morgan N.G., Zecchini D., White R., Petkau A.J., Satoh J.-i., Paty D.W. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J. Neuroimmunol. 86:1998;123-133.
16. Killestein J., Rep M.H.G., Barkhof F., Roos M.T.L., Adér H.J., van Lier R.A.W., Polman C.H. Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells. J. Neuroimmunol. 118:2001;286-294.
17. + T cells are correlated to MRI features of tissue destruction in MS. J. Neuroimmunol. 142:2003;141-148.
18. Kim C.H., Rott L., Kunkel E.J., Genovese M.C., Andrew D.P., Wu L., Butcher E.C. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108:2001;1331-1339.
19. Matsui M., Araya S., Wang H.-Y., Onai N., Matsushima K., Saida T. Circulating lymphocyte subsets linked to intracellular cytokine profiles in normal humans. Clin. Exp. Immunol. 134:2003;225-231.
20. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.-P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50:2001;121-127.
21. Nguyen L.T., Ramanathan M., Munschauer F., Brownscheidle C., Krantz S., Umhauer M., Miller C., DeNardin E., Jacobs L.D. Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients. J. Clin. Immunol. 19:1999;179-185.
22. Nguyen L.T., Ramanathan M., Weinstock-Guttman B., Baier M., Brownscheidle C., Jacobs L.D. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J. Neurol. Sci. 209:2003;93-99.
23. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343:2000;938-952.
24. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology. 45:1995;S11-S15. (Suppl.).
25. Panitch H.S., Hirsch R.L., Schindler J., Johnson K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
26. Porrini A.M., Gambi D., Malatesta G. Memory and naive CD4+ lymphocytes in multiple sclerosis. J. Neurol. 239:1992;437-440.
27. Ramírez F., Fowell D.J., Puklavec M., Simmonds S., Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156:1996;2405-2412.
28. Schluep M., van Melle G., Henry H., Städler C., Roth-Wicky B., Magistretti P.J. Assessing multiple sclerosis activity: is the in vitro production of tumor necrosis factor-α, interleukins 2, 6, 4, and 10, and immunoglobulin G of value? J. Neurol. 246:1999;1041-1050.
29. Scolozzi R., Boccafogli A., Tola M.R., Vicentini L., Camerani A., Degani D., Granieri E., Caniatti L., Paolino E. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. J. Neurol. Sci. 108:1992;93-98.
30. + interferon-γ- and tumor necrosis factor-α-secreting T lymphocytes in multiple sclerosis patients. Ann. Neurol. 47:2000;269-273.
31. Trebst C., Ransohoff R.M. Investigating chemokines and chemokine receptors in patients with multiple sclerosis. Opportunities and challenges. Arch. Neurol. 58:2001;1975-1980.
32. van Oosten B.W., Barkhof F., Scholten P.E.T., von Blomberg B.M.E., Adér H.J., Polman C.H. Increased production of tumor necrosis factor α, and not of interferon γ, preceding disease activity in patients with multiple sclerosis. Arch. Neurol. 55:1998;793-798.
33. Voorthuis J.A., Uitdehaag B.M., De Groot C.J., Goede P.H., van der Meide P.H., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol. 81:1990;183-188.
34. Wang H.-Y., Matsui M., Araya S.-i., Onai N., Matsushima K., Saida T. Chemokine receptors associated with immunity within and outside the central nervous system in early relapsing-remitting multiple sclerosis. J. Neuroimmunol. 133:2002;184-192.
35. Wang H.-Y., Matsui M., Saida T. Immunological disturbances in the central nervous system linked to MRI findings in multiple sclerosis. J. Neuroimmunol. 125:2002;149-154.